stockrowOPKO Health, Inc. (OPK) vs GeneDx Holdings Corp. (WGS)
- OPKO Health, Inc. OPK 1.82 +4.00%
- GeneDx Holdings Corp. WGS 65.35 +1.54%
OPKO Health, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. GeneDx Holdings Corp. is the larger, with a market value of $1.9B against $1.3B — 1.5× the size. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against −21.9%. GeneDx Holdings Corp. has the higher net margin (−23.4% vs −29.5%) and the lower return on invested capital (−27.7% vs −6.72%). Across the 18 metrics below, GeneDx Holdings Corp. leads on 11 and OPKO Health, Inc. on 7.
Valuation
Profitability
| Metric | OPK | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 46.22% | 69.37% | 48.32% |
| Operating margin | (25.46%) | (20.34%) | (5.68%) |
| Net margin | (29.51%) | (23.40%) | (4.10%) |
| Free cash flow margin | (26.91%) | (16.68%) | 0.00% |
| Return on equity | (12.23%) | (40.80%) | 0.00% |
| Return on assets | (7.64%) | (22.50%) | (6.05%) |
| Return on invested capital | (6.72%) | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack